Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Originally developed for type 2 diabetes management, it has seen its applications expand considerably due to its effects on appetite, body weight, and metabolic function
No completed Phase II/III trial
Additional areas of exploration include its role in -adrenergic receptor signaling within adipose tissue, mechanisms tied to connective tissue and cartilage research, and its noted oral bioactivity in laboratory modelsan uncommon characteristic for small peptides
ROS generation induced by HCV infection triggers anti-3-hydroxysterol 24-reductase (DHCR24) antibody production, suggesting that DHCR24 may be used as a prognostic biomarker for hepatitis C progression to hepatocellular carcinoma 56,97
@Smont I'm not allowed to give dosing recommendations on ma research chemical products
Because AOD-9604 works peripherally on fat tissue through beta-3 adrenergic receptors without affecting central appetite pathways, there is no adaptation of hunger-regulating systems and therefore no rebound effect when stopping
